Related Experiment Video
Updated: Jan 20, 2026

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
Chronic wounds: the challenges of appropriate management
1Vascular Nurse Consultant, Mid Yorkshire NHS Trust; Lecturer, University of Huddersfield Chair of the Legs Matter campaign.
Abstract:
The immense burden imposed by chronic wounds-those persisting over 6 weeks despite active intervention-on patients and health services is well recognised. There are various reasons for why a wound fails to progress towards closure, and clinicians must investigate the underlying cause of wound chronicity, as this information guides the management of such wounds. The TIME framework (T=tissue; I=infection/inflammation; M=moisture balance; E=wound edges) is a useful tool for practitioners to systematically undertake wound assessment and product selection. This article discusses chronic wound management based on the TIME framework, examining the aspects to be considered when managing chronic wounds. It also describes the process of dressing selection for overcoming the various barriers to wound healing, specifically discussing the AQUACEL family of dressings.
Related Concept Videos
09:17Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
06:55Protocol to Create Chronic Wounds in Diabetic Mice
Chronic wounds are developed from acute wounds on a diabetic mouse model by inducing high levels of oxidative stress after a full-thickness cutaneous wound. The wound is treated with inhibitors for catalase and glutathione peroxidase, resulting in impaired healing and biofilm development by bacteria present in the skin...
08:50Fabrication and Characterization of a Conformal Skin-like Electronic System for Quantitative, Cutaneous Wound Management
06:56A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection
07:16Swine Model of Biofilm Infection and Invisible Wounds
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

